Cargando…

Pathways to ensure universal and affordable access to hepatitis C treatment

Direct-acting antivirals (DAAs) have dramatically changed the landscape of hepatitis C treatment and prevention. The World Health Organization has called for the elimination of hepatitis C as a public health threat by 2030. However, the discrepancy in DAA prices across low-, middle- and high-income...

Descripción completa

Detalles Bibliográficos
Autores principales:	Douglass, Caitlin H., Pedrana, Alisa, Lazarus, Jeffrey V., ‘t Hoen, Ellen F. M., Hammad, Radi, Leite, Ricardo Baptista, Hill, Andrew, Hellard, Margaret
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Debate
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6176525/ https://www.ncbi.nlm.nih.gov/pubmed/30296935 http://dx.doi.org/10.1186/s12916-018-1162-z

Ejemplares similares

Affordable treatment and political commitment are crucial to eliminate hepatitis C globally
por: Hellard, Margaret, et al.
Publicado: (2021)

Ensuring access to justice: the need for community paralegals to end AIDS by 2030
por: Hinman, Kati, et al.
Publicado: (2023)

Commentary: University Technology Transfer Has Made a Significant Contribution to Fighting COVID-19 while Ensuring Global Access
por: Stevens, Ashley J.
Publicado: (2022)

Ensuring Access to Affordable Drug Coverage in Medicare
por: Antos, Joseph R.
Publicado: (2005)

Ensuring access to affordable, timely vaccines in emergencies
por: Kate, Elder, et al.
Publicado: (2019)

Fertility care interventions should be provided as the first line options for HIV+ serodiscordant couples who desire children in settings with affordable access to care, regardless of their fertility status
por: Safier, Lauren Zakarin, et al.
Publicado: (2017)

Obligations of low income countries in ensuring equity in global health financing
por: Barugahare, John, et al.
Publicado: (2015)

Closing the access gap for health innovations: an open licensing proposal for universities
por: Chaifetz, Samantha, et al.
Publicado: (2007)

A global investment framework for the elimination of hepatitis B
por: Howell, Jessica, et al.
Publicado: (2021)

Heterogeneity in hepatitis C treatment prescribing and uptake in Australia: a geospatial analysis of a year of unrestricted treatment access
por: Scott, Nick, et al.
Publicado: (2018)

Assessment of service refinement and its impact on repeat HIV testing by client's access to Australia's universal healthcare system: a retrospective cohort study
por: Ryan, Kathleen E, et al.
Publicado: (2019)

Innovative strategies for the elimination of viral hepatitis at a national level: A country case series
por: Schröeder, Sophia E., et al.
Publicado: (2019)

Data Access Committees
por: Cheah, Phaik Yeong, et al.
Publicado: (2020)

The Brazilian comprehensive response to hepatitis C: from strategic thinking to access to interferon-free therapy
por: Mesquita, Fabio, et al.
Publicado: (2016)

Noncommunicable diseases, access to essential medicines and universal health coverage
por: Beran, David, et al.
Publicado: (2019)

The Berlin Hepatitis C Manifesto: access to prevention, testing, treatment and care for people who use drugs
por: Schatz, Eberhard, et al.
Publicado: (2016)

Highlights from the 3rd international HIV/viral hepatitis Co-infection meeting - HIV/viral hepatitis: improving diagnosis, antiviral therapy and access
por: Maponga, Tongai G., et al.
Publicado: (2017)

Open access: the view of the Public Library of Science
por: BARBOUR, V, et al.
Publicado: (2006)

Open access: the view of a commercial publisher
por: ROBINSON, A
Publicado: (2006)

Access to pain treatment as a human right
por: Lohman, Diederik, et al.
Publicado: (2010)

Minding the gap: access to palliative care and the homeless
por: Huynh, Lise, et al.
Publicado: (2015)

Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment
por: Wouters, Olivier J, et al.
Publicado: (2021)

Employing human rights frameworks to realize access to an HIV cure
por: Meier, Benjamin Mason, et al.
Publicado: (2015)

Making a COVID-19 vaccine that works for everyone: ensuring equity and inclusivity in clinical trials
por: Pepperrell, Toby, et al.
Publicado: (2021)

Market access agreements for pharmaceuticals in Europe: diversity of approaches and underlying concepts
por: Jarosławski, Szymon, et al.
Publicado: (2011)

Canada and access to medicines in developing countries: intellectual property rights first
por: Lexchin, Joel
Publicado: (2013)

Why should HCWs receive priority access to vaccines in a pandemic?
por: Symons, Xavier, et al.
Publicado: (2021)

The commercialization of university-based research: Balancing risks and benefits
por: Caulfield, Timothy, et al.
Publicado: (2015)

Syrian refugees in Lebanon: the search for universal health coverage
por: Blanchet, Karl, et al.
Publicado: (2016)

Syringe access for the prevention of blood borne infections among injection drug users
por: Stancliff, Sharon, et al.
Publicado: (2003)

One and done? Equality of opportunity and repeated access to scarce, indivisible medical resources
por: Huesch, Marco D
Publicado: (2012)

Comment on: Simple implantation is safe for patients with totally implantable venous access ports
por: Becker, Felix, et al.
Publicado: (2021)

Artificial intelligence and medical research databases: ethical review by data access committees
por: McKay, Francis, et al.
Publicado: (2023)

Debate: Limitations on universality: the "right to health" and the necessity of legal nationality
por: Kingston, Lindsey N, et al.
Publicado: (2010)

Towards the eradication of HPV infection through universal specific vaccination
por: Crosignani, Piergiorgio, et al.
Publicado: (2013)

Ethical considerations of universal vaccination against human papilloma virus
por: Navarro-Illana, Pedro, et al.
Publicado: (2014)

Building capacity for dissemination and implementation research: one university’s experience
por: Brownson, Ross C., et al.
Publicado: (2017)

Bridging access gaps experienced by the underserved: the need for healthcare providers to look within for answers
por: Elrod, James K., et al.
Publicado: (2017)

Too much safety? Safeguards and equal access in the context of voluntary assisted dying legislation
por: McDougall, Rosalind, et al.
Publicado: (2020)

Quality use of medicines within universal health coverage: challenges and opportunities
por: Wagner, Anita K, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_tu49n9a80g6kitvpmf045joatc